Cargando…
Stabilization of vulnerable plaque in the ACS patient: evidence from HUYGENS studies
The introduction of PCSK9 inhibitors in addition to statin therapy allowed better control of LDL-C plasma levels with a subsequent reduction of cardiovascular events. Human atherosclerosis has been previously considered an irreversible condition; studies firstly based on angiography imaging and seco...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132721/ https://www.ncbi.nlm.nih.gov/pubmed/37125301 http://dx.doi.org/10.1093/eurheartjsupp/suad013 |